NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Persista Bio Inc.

Persista Bio Inc.

Private
Ithaca, New YorkHealthcare & Life Scienceshttps://www.persistabio.com/

Last Round

Pre Seed

Feb 5, 2026

Total Funding Raised

$2.4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Persista Bio Inc. is a biotechnology company that develops an oxygenated cell therapy platform designed to enable long-term, immunosuppression-free cell implants for the treatment of Type 1 diabetes and other chronic conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

cell therapyimplantable devicecell encapsulationtype 1 diabetesbiotechbioengineeringelectrochemical oxygenationregenerative medicinemedical devicebiomaterialspreclinical researchdrug deliverybio-implantbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Persista Bio Inc. Comps

Public and private peers based on sector, stage, and business model.

Persista Bio Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Persista Bio Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 5, 2026
AcceleratorOct 1, 2025
GrantSep 23, 2025
SeedSep 23, 2025

Key People

Founding team and executive leadership

Linda Ann Tempelman

Chief Executive Officer

Executive Team

Persista Bio Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 5, 2026

    Monthly visitors increased 457% MoM.

Persista Bio Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Persista Bio Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Persista Bio Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersIthaca, New York
Employee Range11
Year Founded2023
Last FundingFeb 5, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.